● Not Yet Recruiting

A Study to Assess the Safety and Efficacy of AGN-151586 Injections for the Treatment of Moderate to Severe Forehead Lines (FHL) in Adult Participants

Condition: Forehead Lines · Sponsor: AbbVie

PhasePhase 2

Planned participants80

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The objective of this study is to evaluate the safety and efficacy of AGN-151586 for the treatment of moderate to severe forehead lines (FHL) in adult participants.

This description comes directly from the study's public registry record.

Talk to the study team

ABBVIE CALL CENTER · 844-663-3742 · abbvieclinicaltrials@abbvie.com

Always discuss trial participation with your own doctor first.

Locations (0)

Locations not yet listed on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07730554